ask="N/A"
ask_size="N/A"
average_daily_volume="110526"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="+0.00"
change_from_200_day_moving_average="-0.31"
change_from_50_day_moving_average="-0.14"
change_from_52_week_high="-1.61"
change_From_52_week_low="0.24"
change_in_percent="+0.00%"
close="1.98"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.35"
ebitda="-8.49M"
eps_estimate_current_year="-0.31"
eps_estimate_next_quarter="-0.06"
eps_estimate_next_year="-0.33"
ex_dividend_date="N/A"
float_shares="13184000"
high="2.01"
high_52_weeks="3.59"
last_trade_date="2/16/2017"
last_trade_price="1.98"
last_trade_size="100"
last_trade_time="4:02pm"
low="1.96"
low_52_weeks="1.74"
market_capitalization="26.49M"
moving_average_200_day="2.29"
moving_average_50_day="2.12"
name="Can-Fite Biopharma Ltd Sponsore"
notes="N/A"
one_year_target_price="5.00"
open="1.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.67%"
percent_change_from_50_day_moving_average="-6.77%"
percent_change_from_52_week_high="-44.85%"
percent_change_from_52_week_low="+13.79%"
previous_close="1.98"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.52"
price_per_sales="133.33"
revenue="198676.00"
shares_outstanding="13379000"
short_ratio="4.89"
stock_exchange="ASE"
symbol="CANF"
volume="50953"
weeks_range_52="1.74 - 3.59"
